Written by a parent, not a doctor. Nothing here is medical advice.

Childhood Cancer Lantern
Search Saved

Indiana program

Comparing the cost of chemotherapy pills and infusions

Indiana's oral chemotherapy rule compares coverage for pills with coverage for chemotherapy through a drip.

What it is

Indiana's oral chemotherapy rule compares coverage for pills with coverage for chemotherapy through a drip.

Chemo pills usually come through a pharmacy, which puts the charge in a different part of the plan. Indiana's guidance, dating from 2009, says a plan that covers both should not treat the pill worse than the drip. It is a comparison, not a dollar cap, and a plan where the employer pays its own claims is outside it.

Eligibility rules
  • The statutory health-plan definition covers specified accident and health policies and HMO contracts.
  • A private-employer self-funded ERISA plan generally falls outside this mandate. The plan's actual legal status matters.
  • The Indiana comparison applies to covered accident-and-sickness insurance policies and HMO coverage that provide both oral and intravenous or injected cancer chemotherapy. Employer size alone does not remove the rule from an insured policy. A self-funded private ERISA plan is generally outside the mandate; a state, school, municipal or church plan needs its actual funding and governing-law provisions checked rather than an assumption from its employer name.
What you get
  • A check that covered chemotherapy pills face no less favorable limits or cost sharing than infusions.
What the help includes
  • The comparison concerns benefit limits and cost sharing, not whether pills and infusions are medically interchangeable.
  • The oncologist chooses the medically appropriate treatment.
If you decide to apply
  1. Ask the oncology pharmacist and insurer to explain the oral and intravenous benefits in writing.
  2. Have the pharmacy charge and explanation of benefits ready.
  3. Ask the Department of Insurance about a complaint if the plan's comparison appears wrong.

Oncology pharmacist, insurer and Indiana Department of Insurance · Official page ↗

After you ask
  • The insurer can explain how the benefits compare before a complaint is reviewed by the state.
Good to know

The comparison applies when the plan covers both routes. It is not a promise that every chemotherapy prescription has a fixed dollar cap.

Other details
  • Your answers here do not settle the child's actual prescriptions. The pharmacist and insurer compare the prescribed drug and the benefits that apply to it.
Official sources
Ask your social worker

“If chemotherapy pills are part of treatment, how should their cost compare with infusions under our plan? What limits apply, and could you help request a review if the pill benefit is worse?”

Why I’m asking: I want to understand a pharmacy charge without assuming the treatment route can simply be changed.

More background and detailed requirements
Additional program information and published rules

Who does what

The three parts, side by side. The agency decides; nobody on this page does.

You

Compare the pharmacy charge with the hospital charge and ask the plan in writing.

Your social worker

The specialty pharmacy can show what the plan charged.

The care team

The oncology pharmacist can say whether an intravenous equivalent exists.

Who decides
The insurer; the Department of Insurance takes complaints.
Ask your social worker
“My child is on chemotherapy tablets. Can we ask the plan in writing how that benefit compares with intravenous chemotherapy under Indiana guidance?”

How to apply

First step: Ask the plan in writing how the oral chemotherapy benefit compares with the intravenous one.

  1. Ask the plan in writing how the oral benefit compares with the intravenous one.
  2. If the pill costs more, ask the plan to say why in writing and complain to the Department of Insurance.

Where it starts: Write to the plan asking how the oral chemotherapy benefit compares with the intravenous benefit, and complain to the Department of Insurance if it is worse.

What to gather

  • The pharmacy receipts
  • The plan booklet
  • The oncology pharmacist's note on the drug

How long: As long as the plan takes to answer in writing.

What a yes looks like

The plan reprices the tablets to match the intravenous benefit.

What a no looks like, and the next move

Ask the plan to state in writing which statute it thinks applies, and complain to the Department of Insurance.

Watch out

  • The controlling comparison is IC 27-8-32, including section 5, with the HMO cross-reference in IC 27-13-7-20. Covered oral chemotherapy must have no less favorable dollar limits or cost sharing than covered intravenous or injected chemotherapy. This comparison does not establish a fixed prescription price or make every prescription free.
  • It applies where the plan covers both routes. If it covers only one, the comparison does not arise.

Dates that change this

2009-10-26: The controlling comparison is IC 27-8-32, including section 5, with the HMO cross-reference in IC 27-13-7-20. Covered oral chemotherapy must have no less favorable dollar limits or cost sharing than covered intravenous or injected chemotherapy. This comparison does not establish a fixed prescription price or make every prescription free.

The numbers and the rules

The arcane layer, kept on purpose. Checked September 11, 2026.

What it is worth

Where both are covered, an Indiana plan should not charge more for chemotherapy you swallow than for chemotherapy through a drip.

Legal protection: Oral chemotherapy no less favourable in dollar limits and cost sharing than intravenous or injectable chemotherapy, where both are covered

What it costs the family: None.

The eligibility facts, as published

Plan type
The Indiana comparison applies to covered accident-and-sickness insurance policies and HMO coverage that provide both oral and intravenous or injected cancer chemotherapy. Employer size alone does not remove the rule from an insured policy. A self-funded private ERISA plan is generally outside the mandate; a state, school, municipal or church plan needs its actual funding and governing-law provisions checked rather than an assumption from its employer name.

The trap: The controlling comparison is IC 27-8-32, including section 5, with the HMO cross-reference in IC 27-13-7-20. Covered oral chemotherapy must have no less favorable dollar limits or cost sharing than covered intravenous or injected chemotherapy. This comparison does not establish a fixed prescription price or make every prescription free.

Where I read this

← Back to your options